NEVVI Medicare utilization intelligence
or

← back

Provider profile

PATEL, KRISHNA MD

Medical Oncology · NPI 1619263183 · ROUND ROCK, TX

1
Groups
64
Codes · 2024
39,785
Disclosed services

PATEL, KRISHNA is a Medical Oncology in ROUND ROCK, TX, a member of 1 medical group, who billed 64 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

39,785
disclosed services
64
codes billed to Medicare Part B
Prior year · CY2023 16,012 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1756 Injection, iron sucrose, 1 mg
J1453 Injection, fosaprepitant, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0897 Injection, denosumab, 1 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J2469 Injection, palonosetron hcl, 25 mcg
80053 Blood test, comprehensive group of blood chemicals
88185 Flow cytometry technique for dna or cell analysis, each additional marker
J9190 Injection, fluorouracil, 500 mg
83735 Magnesium level
J1626 Injection, granisetron hydrochloride, 100 mcg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
82784 Gammaglobulin (immune system protein) measurement
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
82728 Ferritin (blood protein) level
83550 Iron binding capacity
83540 Iron level
83521 Measurement of immunoglobulin light chains
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
83615 Lactate dehydrogenase (enzyme) level
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
J3475 Injection, magnesium sulfate, per 500 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
85007 Microscopic examination for white blood cells with manual cell count
84443 Blood test, thyroid stimulating hormone (tsh)
96375 Injection of additional new drug or substance into vein
96415 Administration of chemotherapy into vein, each additional hour
85055 Reticulated (young) platelet measurement
J3489 Injection, zoledronic acid, 1 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
82378 Carcinoembryonic antigen (cea) protein level
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J1200 Injection, diphenhydramine hcl, up to 50 mg
85046 Red blood count automated, with additional calculations
J7030 Infusion, normal saline solution , 1000 cc
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
96417 Administration of additional new drug or substance into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
J3490 Unclassified drugs
71260 Ct scan of chest with contrast
96360 Infusion into a vein for hydration, 31-60 minutes
84153 Psa (prostate specific antigen) measurement, total
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
74177 Ct scan of abdomen and pelvis with contrast
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
G6013 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev
96523 Irrigation of implanted venous access drug delivery device
82232 Beta-2 microglobulin (protein) level
88184 Flow cytometry technique for dna or cell analysis, first marker
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
96361 Infusion into a vein for hydration, each additional hour
96411 Administration of additional new drug or substance into vein using push technique
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
71250 Ct scan of chest without contrast
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.